Vimarsana
Biggest News Aggregation in the World

These Part News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from These Part. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In These Part Today - Breaking & Trending Today

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update - Vimarsana News

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

Published: March 29, 2024

- Data for masked anti-CTLA-4 SAFEbody® ADG126 highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable colorectal cancer with higher, more...

Source: marketscreener.com
Related Topics:
United StatesPeter LuoZhu LiRaymond TamAdagene SafebodyAsia PacificUlf GrawunderMervyn TurnerYan LiAndy Yiu Leung CheungAudit CommitteeCompensation CommitteeDynamic Precision LibraryCorporate Governance CommitteeAdagene IncStrategy Committee Of The BoardExchange CommissionInformation TechnologyMerck Co IncEuropean UnionAmerican Society Of Clinical OncologyDevelopment Rd ExpensesChina CenterCompensation Committee Of The BoardMerck Sharp Dohme
Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) - Vimarsana News

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Published: February 9, 2024

- Interim data from additional MSS CRC patients dosed at 10 mg/kg every three weeks in combination with pembrolizumab anticipated in 2024 at a medical conference - - Initiated evaluation of...

Source: marketscreener.com
Related Topics:
United StatesAsia PacificPeter LuoDynamic Precision LibraryAdagene IncExchange CommissionChina CenterEuropean UnionMerck Sharp DohmeMerck Co IncDrug EvaluationProject OptimusThese PartMerck Sharp